Congresul in oncologie ASCO 2015 - 29 mai- 2 iunie American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting

Secțiunea: Tratament cancer in strainatate
2 comentarii 1
1 Violeta Astratinei
30-05-2015, 03:13

Membru din 16-02-2015

Subiecte: 5

Comentarii: 11

Spre informare - stiri recente de la ASCO2015

ASCO 2015 , 29 May
Terapiile imunologice noi de tip anti-PD1, cunoscute pentru melanoma, au aratat eficacitate si in cancerul de ficat, colorectal, endometrial, plaman, cap si gat.
''Recent data demonstrate effectiveness of immunotherapy drugs anti-PD1 not only in melanoma, but in advanced liver, head and neck, lung, and colorectal cancers...''

GENOMIC MARKER PREDICTS ANTI-PD-1 RESPONSE IN SEVERAL CANCERS
NIVOLUMAB SHOWS HIGHLY PROMISING ACTIVITY IN ADVANCED LIVER CANCER IN EARLY-STAGE TRIAL
PEMBROLIZUMAB SHOWS PROMISING ACTIVITY AGAINST HEAD AND NECK CANCER
NIVOLUMAB EXTENDS SURVIVAL FOR PATIENTS WITH THE MOST COMMON LUNG CANCER


Mai mult aici http://www.asco.org/press-center/new-immunotherapies-multiple-hard-treat-cancers
Violeta Astratinei
Patient advocate in Melanoma Network Patient Europe
http://www.melanomapatientnetworkeu.org/
Fondator comunitatea de pacienti Melanom Romania
http://www.melanomromania.com
https://www.facebook.com/melanomromania
@MelanomRomania
2 Violeta Astratinei
30-05-2015, 03:20

Membru din 16-02-2015

Subiecte: 5

Comentarii: 11

ASCO 2015

La acest link se pot cauta rezumate ale cercetarilor pentru diferite cancere/arii de interes.
http://abstracts.asco.org/156/CatView_156_S.html
Violeta Astratinei
Patient advocate in Melanoma Network Patient Europe
http://www.melanomapatientnetworkeu.org/
Fondator comunitatea de pacienti Melanom Romania
http://www.melanomromania.com
https://www.facebook.com/melanomromania
@MelanomRomania
Răspunde la topic
2 comentarii 1
Trimite(Share) pe Facebook
Mergi sus
Trimite linkul pe Whatsapp